Why does Wegovy take 17 weeks to reach full dose?

The 17-week titration reduces gastrointestinal side effects (nausea, vomiting, diarrhea). Each 4-week step allows the body to adapt to increased GLP-1 receptor stimulation before stepping up. Faster escalation is associated with higher rates of discontinuation.

Can I stay at a lower Wegovy dose long term?

Yes. FDA guidance allows maintenance at 1.7 mg or even 1.0 mg weekly if 2.4 mg is not tolerated. Clinical efficacy is reduced but still meaningful at lower doses. Discuss with your prescriber.

Is Ozempic's 2.0 mg dose new?

Yes. The FDA approved Ozempic 2.0 mg weekly in March 2022 for type 2 diabetes patients needing additional glycemic control on 1.0 mg. It is not currently approved for weight management.

What is the Rybelsus maintenance dose?

14 mg daily is the maximum approved Rybelsus dose. Some patients achieve glycemic goals at 7 mg daily and remain there as maintenance.

Can I switch from Ozempic to Wegovy without re-titrating?

Only if you are already tolerating an equivalent Wegovy dose. For example, a patient on Ozempic 1 mg weekly may start Wegovy at 1 mg weekly. A patient on Ozempic 0.5 mg should begin Wegovy escalation at 0.5 mg. Confirm with your prescriber.

Wegovy HD refers to higher-dose maintenance options (up to 7.2 mg weekly) studied in the STEP UP trial for patients who tolerate 2.4 mg but need additional weight reduction. Availability and FDA approval status vary — check with your pharmacy.

How do I take Rybelsus?

In the morning, on an empty stomach, with no more than 4 oz (120 mL) of plain water. Wait at least 30 minutes before eating, drinking anything else, or taking any other oral medication. Do not split, crush, or chew the tablet.

Does dose titration reset if I stop for a few weeks?

If you miss more than 2 consecutive weekly doses of subcutaneous semaglutide, many prescribers recommend restarting at a lower dose to minimize GI side effects. Exact restart depends on how long you paused — consult your prescriber.

Semaglutide Dosage Chart

Every FDA-approved semaglutide product, its titration schedule, and maintenance dose — in one table. Sourced from current prescribing information.

Reviewed by Audrey P. Baysa, RPh, MSc · Last reviewed April 21, 2026

Convert to units

Full Titration Chart — All Products

Weeks	Wegovy (inj.)	Wegovy HD (inj.)	Wegovy Oral (25 mg)	Ozempic	Rybelsus (oral)
1 – 4	0.25 mg / wk	0.25 mg / wk	3 mg / day	0.25 mg / wk	3 mg / day
5 – 8	0.5 mg / wk	0.5 mg / wk	7 mg / day	0.5 mg / wk	7 mg / day
9 – 12	1.0 mg / wk	1.0 mg / wk	14 mg / day	1.0 mg / wk (maintenance)	14 mg / day (maintenance)
13 – 16	1.7 mg / wk	1.7 mg / wk	25 mg / day	(or up to 2.0 mg / wk)	—
17 – 20	2.4 mg / wk (maintenance)	2.4 mg / wk	25 mg / day (maintenance)	1.0 mg or 2.0 mg / wk	—
21 – 24	2.4 mg / wk	4.8 mg / wk	25 mg / day	1.0 or 2.0 mg / wk	—
25+ (maintenance)	2.4 mg / wk	up to 7.2 mg / wk	25 mg / day	1.0 or 2.0 mg / wk	14 mg / day

Sources: Wegovy FDA PI, Ozempic FDA PI, Rybelsus FDA PI, and published SUSTAIN FORTE and STEP UP trial data. Wegovy HD (escalated maintenance) based on the STEP UP trial protocol; availability varies.

Slowed titration is common. If nausea, vomiting, or other GI effects persist at a given step, your prescriber may keep you at that dose for an additional 4 weeks before advancing. This is standard practice and does not affect long-term efficacy.

Quick summary per product

Wegovy (injection)

Weight loss

Indication: chronic weight management
Titration: 17 weeks (0.25 → 2.4)
Maintenance: 2.4 mg weekly
Route: subcutaneous, once weekly

Wegovy dosage details →

Wegovy HD

Extended

Indication: weight management, escalated
Titration: through 2.4, then step to 4.8, 7.2
Maintenance: up to 7.2 mg weekly
Based on: STEP UP trial (2024)

HD details →

Wegovy Oral

Oral

Indication: weight management (oral)
Titration: 3 → 7 → 14 → 25 mg daily
Maintenance: 25 mg daily
Route: oral tablet, morning empty stomach

Oral details →

Ozempic

Diabetes

Indication: type 2 diabetes
Titration: 0.25 → 0.5 → 1.0 (→ 2.0)
Maintenance: 0.5, 1.0, or 2.0 mg weekly
Route: subcutaneous, once weekly

Ozempic details →

Rybelsus

Oral · Diabetes

Indication: type 2 diabetes
Titration: 3 → 7 → 14 mg daily
Maintenance: 7 or 14 mg daily
Route: oral tablet, morning empty stomach

Rybelsus details →

Compounded

Variable

Compounded semaglutide from a 503A or 503B pharmacy is supplied in vials. Concentrations vary by pharmacy (typically 2.5, 5, or 10 mg/mL). Always verify your vial and use the converter.

Units converter →

How we built this chart

Every dose on this page comes from the current FDA-approved prescribing information for each product. We verify these against Novo Nordisk's published patient-information leaflets and, for off-label or emerging regimens (such as Wegovy HD and Wegovy Oral), the published clinical trial protocols.

Primary sources

Wegovy — FDA prescribing information (PDF) · Drugs@FDA overview
Ozempic — FDA prescribing information (PDF) · Drugs@FDA overview
Rybelsus — FDA prescribing information (PDF) · Drugs@FDA overview
STEP 1 (Wegovy efficacy): Wilding JPH, et al. NEJM, 2021. PubMed · NEJM
SUSTAIN-6 (Ozempic CV outcomes): Marso SP, et al. NEJM, 2016. PubMed · NEJM
SUSTAIN FORTE (Ozempic 2 mg vs 1 mg): Frías JP, et al. Lancet Diabetes & Endocrinology, 2021. PubMed
STEP 4 (continued vs discontinued semaglutide): Rubino D, et al. JAMA, 2021. PubMed

Last FDA label verified: April 2026. We re-check labels quarterly. If you find a discrepancy, email us.

FAQ

Related tools

💉